SCHEMBL16858053

SCHEMBL16858053

OC(O)c1ccc2nccn2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.47
CLK4 Q9HAZ1 3/20 0.42
MAPK14 Q16539 2/20 0.42
MAP4K4 O95819 2/20 0.42
PRKACA P17612 2/20 0.42
CDK8 P49336 2/20 0.42
LRRK2 Q5S007 2/20 0.42
KDR P35968 11/20 0.41
RET P07949 3/20 0.41
JAK2 O60674 2/20 0.41
GSK3A P49840 2/20 0.41
RPS6KA3 P51812 2/20 0.41
LIMK1 P53667 2/20 0.41
MAP2K1 Q02750 2/20 0.41
ALK Q9UM73 2/20 0.41
DYRK1B Q9Y463 2/20 0.41
AURKA O14965 1/20 0.40
DAPK3 O43293 1/20 0.40
ABL1 P00519 1/20 0.40
NTRK1 P04629 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2067929 0.81 DYRK1A (0.47) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL21193347 0.81 DYRK1A (0.47) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL5487802 0.74 DYRK1A (0.52) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL30838565 0.72 KDR (0.40) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL21385786 0.70 DYRK1A (0.38) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL1051267 0.69 DYRK1A (0.52) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL3500436 0.69 DYRK1A (0.52) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL102246 0.69 DYRK1A (0.52) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL2067916 0.69 DYRK1A (0.52) DYRK1ACLK4MAPK14MAP4K4PRKACA
SCHEMBL7514132 0.69 DYRK1A (0.52) DYRK1ACLK4MAPK14MAP4K4PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458172-B2 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives VALO HEALTH, INC. 2016-10-04 US disclosed
US-9458172-B2 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives VALO HEALTH, INC. 2016-10-04 US disclosed
US-20150175621-A1 PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES Valo Health, LLC 2015-06-25 US disclosed
US-20150175621-A1 PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES Valo Health, LLC 2015-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175621-A1 PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES TPMT, TYMS, TYMP DYRK1A 2937/4885CLK4 4675/4885MAPK14 2834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.